Transgenomic's alternatives and competitors
BioDelivery Sciences (NASDAQ: BDSI) is a specialty pharmaceutical company that leverages its novel and proprietary patented drug delivery technologies to develop and co…Transgenomic vs. BioDelivery Sciences International
- Customer References and more
Life Technologies Corporation is a global biotechnology company that provides products and services to customers in the fields of scientific research, genetic analysis …Transgenomic vs. Life Technologies Corporation
- Customer References and more
Lipomics provides metabolite profiling, biomarker discovery and metabolism consultation services to industry and academia. Its quantitative profiling assays are used to…
Caliper Life Sciences operates as a research tools company. The company offers a range of products and services, including molecular solutions for preclinical imaging a…
Top 10 Transgenomic competitors
Compare Transgenomic to Competitors
Solidus Biosciences is a company focused on providing business intelligence in the pharmaceutical and biologic drugs sector. The company's main services include offering insights on life cycle management, brand erosion, generic entry, biosimilars, patents, sales, litigation, and more, all related to pharmaceutical and biologic drugs. The company primarily serves the biopharmaceutical industry. It is based in Troy, New York.
CAPE Technologies specializes in high performance immunotechnology for environmental testing. The company offers a practical immunoassay kit for dioxin and furan analysis, designed to provide rapid and sensitive screening with a reasonable cost. The primary sectors served include environmental monitoring and regulatory compliance industries. It is based in South Portland, Maine.
SideroGen, Inc. is focused on the development and manufacture of biomolecule purification products for applications in the fields of forensic science and clinical genomics. These products will be developed for processing very small samples, common to forensic science and cancer diagnostics. The core technology for these products is based on inert ferro-ceramic, paramagnetic particles of compositions that are specifically designed to be compatible with downstream DNA and protein analysis. This technology and its uses are exclusively owned and were developed by SideroGen, Inc.
Axela is delivering on its mission to provide a simple and effective approach to personalized medicine by exploiting the dotLab System in research markets today to generate tomorrow's diagnostics. This strategy of offering a common technology platform to both markets aims to provide a opportunity to capitalize on discoveries. The approach has already resulted in applications with the potential to address segments of the large, underserved markets of oncology and cardiology that will be the focus of two funded clinical trials this summer and growing installed customer base. For a time these leading clinical researchers can use the direct understanding of protein interactions to develop quantitative assays on a single platform. dot technology has shortened the transition from protein discovery to application. The ability to measure biomolecular complexes in real-time aims to provide for new approaches to disease management.
Kelaroo is a software company specializing in solutions for the pharmaceutical and biotechnology industries. The company offers a suite of proprietary software designed to simplify and streamline chemical reagent inventory management, synthesis outsourcing processes, and bioinformatics discovery programs. Kelaroo's products are tailored to enhance functionality with simple, yet powerful interfaces, without the need for extensive product training. It was founded in 2000 and is based in Solana Beach, California.
The company's core business is and remains the development and production of Active Pharmaceutical Ingredient and parenteral formulations in the the form of solution and Lyophilized injection, in areas like anesthialogy and oncology.